BioNTech SE 22UA-DE:XETRA

*Data is delayed | EUR
Last | 07/30/21 CEST
269.20quote price arrow up+6.20 (+2.36%)
Volume
133,709
52 week range
65.50 - 276.30

...

Loading . . .
  • Open262.50
  • Day High269.50
  • Day Low258.40
  • Prev Close263.00
  • 52 Week High276.30
  • 52 Week High Date07/29/21
  • 52 Week Low65.50
  • 52 Week Low Date12/29/20

Key Stats

  • Market Cap79,303.44M
  • Shares Out241.52M
  • 10 Day Average Volume219,397
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change268.87

KEY STATS

  • Open262.50
  • Day High269.50
  • Day Low258.40
  • Prev Close263.00
  • 52 Week High276.30
  • 52 Week High Date07/29/21
  • 52 Week Low65.50
  • 52 Week Low Date12/29/20
  • Market Cap79,303.44M
  • Shares Out241.52M
  • 10 Day Average Volume219,397
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change268.87

RATIOS/PROFITABILITY

  • EPS (TTM)4.55
  • P/E (TTM)59.16
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO3:2803:28
BioNTech's Ozlem Tureci on malaria vaccine development

Profile

MORE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company...
Address
An der Goldgrube 12
Mainz
55131
Germany